-

BCF, BREF and TBG Companies Seek Global Financial Support to Establish 1000s of Best Cure Pro Health and Medical Centers

WASHINGTON--(BUSINESS WIRE)--Dr. Krishnan Suthanthiran is the Founder and President of the Best Cure Foundation (BCF), a non-profit 501(c)(3) corporation established in Springfield, Virginia, USA, in 2007. He also established the Brachytherapy Research & Education Foundation (BREF) as a non-profit in Springfield, Virginia, USA, in 1987.

Additionally, Suthanthiran founded TeamBest Global (TBG) Companies in 1977 and has acquired several companies over the last 20 years.

Suthanthiran's journey to address cancer began after losing his father to the disease in 1968. He has since dedicated over 50 years to finding ways to lower the cost of treatment and significantly improve clinical outcomes on a global scale.

Health is wealth. A healthy person has many wishes, but a sick person has only one: to get healthy. An ounce of prevention is better than a pound of cure. BCF promotes a Total Health System of Prevention, Early Detection, Effective Treatment for Total Cure, and Proactive Health System with full transparency on clinical outcomes, benefits, and costs.

BCF's goals are to reduce deaths and suffering from cancer, heart disease, diabetes, infectious diseases, and other illnesses by 50% or more, at a lower cost, by 2040 or 2050, or sooner. Suthanthiran launched his Global War on Cancer on April 29, 2015, in memory of his late father.

In recognition of Suthanthiran's contributions and initiatives, Harvard University Medical School in Boston, Massachusetts, USA, began hosting annual conferences on the first anniversary of the launch of Suthanthiran's Global War on Cancer and he had been a keynote speaker.

Suthanthiran has a two-part plan to accomplish his goals. In part one, he plans to establish BCF Pro Health Centers – BCF non-profit proactive, preventive, primary medical, dental and eye care wellness centers. Part two involves the establishment of BCF Medical Centers for Treatment, which will focus on all diseases as specialty medical centers and all of the centers operating 24/7.

As part of this plan, Suthanthiran aims to establish over a million square feet of high-tech manufacturing, office, R&D, packaging, crating, and storage space in the USA and India. TBG currently has available properties in both India and the USA, and these will be supplemented with new spaces to be acquired in both countries.

Suthanthiran has funded all of these activities personally for over 50 years, without any partners, private equity, or other financial contributions from others. However, the current plans are too large to be entirely funded by himself, despite using all of his assets towards these goals. Therefore, he is seeking financial support from others to carry out these significant goals. Please join and contribute. For more information visit www.bestcure.md.

Contacts

Krishnan Suthanthiran, 703-451-2378, krish@teambest.com

TeamBest Global LogoTeamBest Global Logo

TeamBest Global


Release Versions

Contacts

Krishnan Suthanthiran, 703-451-2378, krish@teambest.com

More News From TeamBest Global

To Leaders of Canadian First Nations and Federal/Provincial Governments—Fueling the Future with Kitsault Energy

WASHINGTON--(BUSINESS WIRE)--In 2013, Dr. Suthanthiran, President/Founder of TeamBest Global Companies, announced his dedicated energy pipeline corridor/export port/terminal to carry all of Canada’s energy products to Kitsault, BC, Canada, a town owned by Suthanthiran, northwest of Prince Rupert, BC. Suthanthiran, a healthcare professional, has devoted over fifty years to cheering, helping, and saving lives daily. The dedicated pipeline corridor is now a reality, w/multiple pipelines approved a...

Best Vascular/Novoste Celebrates 24th Anniversary of Vascular Brachytherapy Approval & Use of by US FDA

WASHINGTON--(BUSINESS WIRE)--It’s been over 30 years since the first vascular brachytherapy (VBT) animal experiments and human clinical trials were performed and 24 years since the approval of VBT for human clinical use for the treatment of in-stent coronary artery restenosis by the US FDA on November 3, 2000. Dr. Paul Teirstein, at Scripps Clinic in La Jolla, California, in collaboration with Virginia-based Best Medical International (BMI), began the first randomized, double-blind human clinic...

BCS to Expand Manufacturing of Cyclotrons for Research, Radioisotope Production & Theranostics in India, Europe & USA

WASHINGTON--(BUSINESS WIRE)--Best Cyclotron Systems (BCS), a TeamBest Global Company (TBG), plans to expand its manufacturing operations in India, Europe, and the USA to produce hundreds of cyclotrons annually. Within two years, BCS and TBG will have access to high-energy/high-current 70 MeV and 30 MeV proton beams, as well as 35 MeV alpha, deuteron, and proton multi-particle cyclotrons, and several low-energy proton cyclotrons for research, radioisotope production, and theranostics. In 2024, B...
Back to Newsroom
  1. There was an issue with the authorization server. Please contact support if the issue persists.